Bioqual (Bioqual) EBIT per Share : $5.98 (TTM As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual EBIT per Share?

Bioqual's EBIT per Share for the six months ended in May. 2018 was $5.98. Its EBIT per Share for the trailing twelve months (TTM) ended in May. 2018 was $5.98.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Bioqual's EBIT per Share or its related term are showing as below:

BIOQ's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -1.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Bioqual's EBIT for the six months ended in May. 2018 was $5.34 Mil.

Bioqual EBIT per Share Historical Data

The historical data trend for Bioqual's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual EBIT per Share Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

EBIT per Share

Get a 7-Day Free Trial

1.76

0.75

7.34

5.98

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
EBIT per Share	Get a 7-Day Free Trial										1.76	0.75	0.75	7.34	5.98

Bioqual EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Bioqual's EBIT per Share for the fiscal year that ended in May. 2018 is calculated as

	EBIT per Share		(A: May. 2018 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	5.336	/	0.893
=	5.98

Bioqual's EBIT per Share for the quarter that ended in May. 2018 is calculated as

	EBIT per Share		(Q: May. 2018 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	5.336	/	0.893
=	5.98

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in May. 2018 was $5.98

Bioqual (OTCPK:BIOQ) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Bioqual EBIT per Share Related Terms

Thank you for viewing the detailed overview of Bioqual's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » EBIT per Share

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines